Skip to content

The Association Between Different Markers With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia

The Association Between Clinical, Laboratory and Ultrasonographic Findings With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07125599
Enrollment
284
Registered
2025-08-15
Start date
2020-05-02
Completion date
2025-05-20
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Preeclampsia

Keywords

preeclampsia, complications

Brief summary

pregnant women diagnosed with severe preeclampsia were subjected to • Full history taking including a detailed history of the hypertension state during the current pregnancy (onset, course, current medication, and whether the blood pressure is controlled or not).gravidity , parity mode of delivery any medical disorders, the presence of headache ,blurring of vision and epigastric pain. * Complete physical examination: general (including BMI & blood pressure measurement) and obstetric examinations. * Routine obstetric ultrasound and Doppler indices Including umbilical artery Doppler (RI). * Laboratory investigations : 1\. Complete blood count (CBC). 2 albuminuria will be detected by dipstick kits . 3. Liver enzymes & kidney function. 4.PT,PC,INR. * Pelvic-Abdominal ultrasound to assess the presence of ascites Ultrasound examination will be performed by a consultant obstetrician to detect free fluid in the peritoneal cavity, especially at hepato-renal pouch, sub-splenic area, or para-colic gutters. The presence of ascites will be further confirmed at the time of delivery. 3-All labours will be attended by an expert neonatologist and the following will be recorded: * APGAR score at (1 min). * The further need for neonatal intensive care unit (NICU) admission. * Perinatal death

Detailed description

pregnant women diagnosed with severe preeclampsia were subjected to • Full history taking including a detailed history of the hypertension state during the current pregnancy (onset, course, current medication, and whether the blood pressure is controlled or not).gravidity , parity mode of delivery any medical disorders, the presence of headache ,blurring of vision and epigastric pain. * Complete physical examination: general (including BMI & blood pressure measurement) and obstetric examinations. * Routine obstetric ultrasound and Doppler indices Including umbilical artery Doppler (RI). * Laboratory investigations : 1\. Complete blood count (CBC). 2 albuminuria will be detected by dipstick kits . 3. Liver enzymes & kidney function. 4.PT,PC,INR. * Pelvic-Abdominal ultrasound to assess the presence of ascites Ultrasound examination will be performed by a consultant obstetrician to detect free fluid in the peritoneal cavity, especially at hepato-renal pouch, sub-splenic area, or para-colic gutters. The presence of ascites will be further confirmed at the time of delivery. 3-All labours will be attended by an expert neonatologist and the following will be recorded: * APGAR score at (1 min). * The further need for neonatal intensive care unit (NICU) admission. * Perinatal death

Interventions

None listed

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

1. Maternal age from 18 to 40 years. 2. Gestational age (28\_38) weeks, confirmed by the first day of the last menstrual period or first trimesteric ultrasound 3. All suffering of severe preeclampsia

Exclusion criteria

1. known liver disease 2. Maternal medical disorders rather than hypertension. 3. Rupture of membrane. 4. Renal disorder. 5. History of illicit drug use. 6. Fetal congenital anomalies. 7. The maternal administration of respiratory depressants within 2 hours from the delivery of the fetus (e. g., opioid analgesic ) 8. Associated inflammatory disease or sepsis.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants developed eclampsia3 days after deliveryconvulsions in women with severe preeclampsia

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026